Inhibition of PVR with a Tyrosine Kinase Inhibitor, Dasatinib, in the Swine
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
PURPOSE: We tested the efficacy of dasatinib, a Food and Drug Administration (FDA)-approved tyrosine kinase inhibitor, to prevent proliferative vitreoretinopathy (PVR). METHODS: The effect of dasatinib on RPE sheet growth was determined by measuring enlargement of cultured RPE sheets in the presence or absence of dasatinib. Epithelial-mesenchymal transition (EMT) of RPE cells was assessed by expression of S100A4. A scratch wound assay, cell number count, and type I collagen contraction assay were used to examine the effect of dasatinib on migration, proliferation, and extracellular matrix (ECM) contraction, respectively. Our swine model of experimental PVR with green fluorescent protein-positive (GFP+) RPE cells was used to assess the efficacy of dasatinib in preventing traction retinal detachment (TRD) caused by PVR. Full-field electroretinography and histologic examination were used to determine the retinal toxicity of dasatinib. RESULTS: Dasatinib prevented RPE sheet growth, cell migration, proliferation, EMT, and ECM contraction in a concentration-dependent manner. 0.1 μM dasatinib inhibited nearly 80% of vitreous fluid-stimulated collagen gel contraction. Dasatinib also prevented TRD caused by PVR in vivo. Only 1/11 eyes had a TRD in the presence of dasatinib, while all 11 controls eyes had a TRD. Dasatinib did not cause any detectable toxicity of the retina. CONCLUSIONS: Dasatinib significantly inhibited PVR-related RPE changes in vitro and prevented TRD in an experimental PVR model in the swine without any detectable toxicity. Our data suggested that dasatinib may be effective in the prevention of PVR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor
Hanke, J. H., Gardner, J. P., Dow, R. L., Changelian, P. S., Brissette, W. H., Weringer, E. J., Pollok, B. A., & Connelly, P. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.695 · Cited by 1,939
The parameters of the porcine eyeball
Sanchez, I., Martin, R., Ussa, F., & Fernandez-Bueno, I. (2011) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-011-1617-9 · Cited by 298 · cited 1×
“The swine, in contrast to other species, has an eye with many similarities to the human eye, such as size and anatomy, including a holangiotic retinal vasculature and a cone-enriched area centralis.(43,62) Our study used a swine model of experimental PVR that reproduces the key features found in human PVR,(41) and 0.”
BackgroundThe Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib
Hantschel, O., Rix, U., Schmidt, U., Bürckstümmer, T., Kneidinger, M., Schütze, G., Colinge, J., Bennett, K. L., Ellmeier, W., Valent, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702654104 · Cited by 284
Sonoda, S., Spee, C., Barron, E., Ryan, S. J., Kannan, R., & Hinton, D. R. (2009) · Nature Protocols · doi:10.1038/nprot.2009.33 · Cited by 272 · cited 1×
“Fetal RPE cells, used for induction of PVR in vivo (see below), were isolated from embryonic week 12 swine eyes and cultured as described previously.(40,41) Normal RPE cells without GFP expression as well as GFP-positive RPE cells (GFP-RPE) were used in this study.”
MethodKong, L., Deng, Z., Shen, H., & Zhang, Y. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0632-1 · Cited by 41
Cited by
EMT and EndMT: Emerging Roles in Age-Related Macular Degeneration
Shu, D. Y., Butcher, E., & Saint-Geniez, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124271 · Cited by 292
Li, Q., Lai, K. L., Chan, P. S., Leung, S. C., Li, H. Y., Fang, Y., To, K. K. W., Choi, C. H. J., Gao, Q. Y., & Lee, T. W. Y. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.12.053 · Cited by 67
Nanoparticulate drug delivery to the retina
Li, Q., Weng, J., Wong, S. N., Thomas Lee, W. Y., & Chow, S. F. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00224 · Cited by 59
Microglia Regulate Neuroglia Remodeling in Various Ocular and Retinal Injuries
Paschalis, E. I., Lei, F., Zhou, C., Chen, X. N., Kapoulea, V., Hui, P.-C., Dana, R., Chodosh, J., Vavvas, D. G., & Dohlman, C. H. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1800982 · Cited by 50
Li, Q., Qian, X., Li, H. Y., Lai, K. L., Gao, Q., & Lee, W. Y. T. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120226 · Cited by 26
Metadata
- Authors
- Umazume, K., Liu, L., Scott, P. A., de Castro, J. P. F., McDonald, K., Kaplan, H. J., & Tamiya, S.
- Venue
- Investigative Opthalmology & Visual Science
- Published
- 2013-02-12
- Volume
- 54
- Issue
- 2
- Pages
- 1150
- ISSN
- 0146-0404 (ISSN-L)
- 1552-5783
- OpenAlex
- W2328605102
- Cited by
- 50
- References
- 5
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.